USPTO serial 79144456
GELWEAVE
Reviewed by CopyMark Law Group
Reg. 4705768Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 24, 2015
- Examiner
- MICHELI, ANGELA M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with GELWEAVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan E. Fink
Megan E. Fink Bodman PLC201 South Division Street, Suite 400Ann Arbor, MI 48104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments for treating cardiovascular disease; prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; [ suture materials; ] patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, [ cardiac valves for surgical prostheses, ] stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; [ cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; ] cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 20, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 20, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 20, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 9, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 2, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 6, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 24, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 22, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 22, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 22, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 22, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 18, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 24, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 4, 2016 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Dec 27, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 15, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 30, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 30, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 24, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 27, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 22, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 8, 2015 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Mar 24, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 7, 2015 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Mar 6, 2015 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 19, 2015 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jan 6, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 6, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 17, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 17, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 17, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 25, 2014 | ALIE | ASSIGNED TO LIE | — |
| Nov 7, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 1, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 31, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2014 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 1, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 30, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 30, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 29, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 28, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |